The US Senate Committee on Health, Education, Labor and Pensions advanced the FDA Safety and Landmark Advancements (FDASLA) Act on 14 June with barely a mention of provisions to dramatically overhaul federal cosmetics regulations.
However, one voice emerged from the markup as a potential cosmetics industry ally. In his opening remarks, ranking member Richard...